Papa Medical Inc.
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date			2025-Jun-30
Fiscal Period			Q2-FY2025
Total Revenue			14,711,421$				8,688,749$
Cost Of Revenue			11,062,007$				6,526,070$
Gross Profit			3,649,414$				2,162,679$
Gross Margin			24.81%				24.89%
Operating Expenses			2,678,500$				1,596,678$
Operating Income			970,914$				566,001$
Other Income			(57,442$)				(104,530$)
Interest Income			27,176$				13,594$
Interest Expenses
Income Before Tax			940,648$	789,054$	(186,381$)	304,466$	475,065$
Tax Expenses			319,425$				43,646$
Income from Continuing Operations			621,223$	789,054$	(186,381$)	304,466$	431,419$
Income from Discontinued Operations
Consolidated Income			621,223$	789,054$	(186,381$)	304,466$	431,419$
Net Income			621,223$	789,054$	(186,381$)	304,466$	431,419$
Profit Margin			4.22%				4.97%
Earnings to Minority
Earnings to Common Shareholders			621,223$	789,054$	(186,381$)	304,466$	431,419$
Earnings Per Share, Basic			0.03$				0.02$
Earnings Per Share, Diluted			0.03$				0.02$
Average Shares, Basic			20,000,000				20,000,000
Average Shares, Diluted			20,000,000				20,000,000
EBIT			940,648$	789,054$	(186,381$)	304,466$	475,065$
EBITDA			940,648$	789,054$	(186,381$)	304,466$	475,065$

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation